Christopher W. Murray

781 total citations
15 papers, 390 citations indexed

About

Christopher W. Murray is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cancer Research. According to data from OpenAlex, Christopher W. Murray has authored 15 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Cancer Research. Recurrent topics in Christopher W. Murray's work include Cancer Genomics and Diagnostics (5 papers), Pain Mechanisms and Treatments (4 papers) and Neuropeptides and Animal Physiology (4 papers). Christopher W. Murray is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Pain Mechanisms and Treatments (4 papers) and Neuropeptides and Animal Physiology (4 papers). Christopher W. Murray collaborates with scholars based in United States, Germany and China. Christopher W. Murray's co-authors include Alan Cowan, Alice A. Larson, Monte M. Winslow, A. Cowan, Ian P. Winters, Min K. Tsai, Rui Tang, Jennifer J. Brady, Laura Andrejka and Christian A. Kunder and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and Nature Cell Biology.

In The Last Decade

Christopher W. Murray

14 papers receiving 384 citations

Peers

Christopher W. Murray
Shailaja Kishan Rao United States
Chunqing Zhang China
Xiaofeng Zhao United States
S. Iino Japan
Rozenn Bernard Australia
Stephen W. O'Connor United States
Elena V. Nikonova United States
María Velasco‐Estevez Ireland
Kyoungjoo Cho South Korea
Pankaj Bhalla United States
Shailaja Kishan Rao United States
Christopher W. Murray
Citations per year, relative to Christopher W. Murray Christopher W. Murray (= 1×) peers Shailaja Kishan Rao

Countries citing papers authored by Christopher W. Murray

Since Specialization
Citations

This map shows the geographic impact of Christopher W. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Murray more than expected).

Fields of papers citing papers by Christopher W. Murray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher W. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Murray. The network helps show where Christopher W. Murray may publish in the future.

Co-authorship network of co-authors of Christopher W. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher W. Murray. A scholar is included among the top collaborators of Christopher W. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher W. Murray. Christopher W. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Shuldiner, Emily G., Kálmán Somogyi, Christopher W. Murray, et al.. (2025). EML4−ALK Variant-Specific Genetic Interactions Shape Lung Tumorigenesis. Cancer Discovery. 16(1). 46–65.
2.
Lee, Myung Chang, Hongchen Cai, Christopher W. Murray, et al.. (2023). A multiplexed in vivo approach to identify driver genes in small cell lung cancer. Cell Reports. 42(1). 111990–111990. 15 indexed citations
3.
Gonzalez, Michael, Daniel Lu, Maryam Yousefi, et al.. (2023). Phagocytosis increases an oxidative metabolic and immune suppressive signature in tumor macrophages. The Journal of Experimental Medicine. 220(6). 34 indexed citations
4.
Tang, Rui, Emily G. Shuldiner, Marcus R. Kelly, et al.. (2023). Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth. Nature Cell Biology. 25(1). 159–169. 16 indexed citations
5.
Murray, Christopher W., Jennifer J. Brady, Hongchen Cai, et al.. (2022). LKB1 drives stasis and C/EBP-mediated reprogramming to an alveolar type II fate in lung cancer. Nature Communications. 13(1). 1090–1090. 12 indexed citations
6.
Murray, Christopher W., Jennifer J. Brady, Min K. Tsai, et al.. (2019). An LKB1–SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation. Cancer Discovery. 9(11). 1590–1605. 62 indexed citations
7.
Winters, Ian P., Christopher W. Murray, & Monte M. Winslow. (2018). Towards quantitative and multiplexed in vivo functional cancer genomics. Nature Reviews Genetics. 19(12). 741–755. 34 indexed citations
8.
Winters, Ian P., Christopher W. Murray, & Monte M. Winslow. (2018). Publisher Correction: Towards quantitative and multiplexed in vivo functional cancer genomics. Nature Reviews Genetics. 19(12). 801–801. 1 indexed citations
9.
Shanmugam, Vijayalakshmi, Ramesh K. Ramanathan, Nicole Lavender, et al.. (2014). Whole genome sequencing reveals potential targets for therapy in patients with refractory KRASmutated metastatic colorectal cancer. BMC Medical Genomics. 7(1). 36–36. 17 indexed citations
10.
Murray, Christopher W. & A. Cowan. (1991). Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.. Journal of Pharmacology and Experimental Therapeutics. 257(1). 335–341. 26 indexed citations
11.
Murray, Christopher W., Alan Cowan, & Alice A. Larson. (1991). Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain. 44(2). 179–185. 129 indexed citations
12.
Murray, Christopher W. & Alan Cowan. (1990). [d-Pen2,d-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice. Psychopharmacology. 102(3). 425–426. 14 indexed citations
13.
Murray, Christopher W. & A. Cowan. (1990). Formalin nociception in the mouse does not lead to increased spinal serotonin turnover. Neuroscience Letters. 108(1-2). 132–137. 6 indexed citations
14.
Murray, Christopher W. & A. Cowan. (1988). Neuroadaptation of rats to kappa agonists U-50,488 and tifluadom.. PubMed. 81. 136–42. 7 indexed citations
15.
Murray, Christopher W., et al.. (1987). Neurokinin-induced salivation in the anesthetized rat: a three receptor hypothesis.. Journal of Pharmacology and Experimental Therapeutics. 242(2). 500–506. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shailaja Kishan Rao Breakdown of academic impact, for papers by Chunqing Zhang Breakdown of academic impact, for papers by Xiaofeng Zhao Breakdown of academic impact, for papers by S. Iino Breakdown of academic impact, for papers by Rozenn Bernard Breakdown of academic impact, for papers by Stephen W. O'Connor Breakdown of academic impact, for papers by Elena V. Nikonova Breakdown of academic impact, for papers by María Velasco‐Estevez Breakdown of academic impact, for papers by Kyoungjoo Cho Breakdown of academic impact, for papers by Pankaj Bhalla
Rankless by CCL
2026